NIH-funded research NIH-funded research

Onsite PTSD Treatment to Improve MOUD Outcomes for people who inject drugs

Official title: Onsite PTSD Treatment to Improve MOUD Outcomes (OPTIMO): a hybrid Type 1 effectiveness-implementation trial of PTSD care in community-based settings that serve people who use drugs

Funded at City College of New York · NIH-11538491 · Data updated 2026-11-12

A community-based program will adapt a PTSD therapy and deliver it alongside opioid-use treatments to help people who inject drugs stay engaged in care and improve outcomes.

More PTSD research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionCity College of New York
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 30, 2023
Project endAugust 31, 2030
Funding year2026
Award (this year)$1,162,298
NIH project number4R33DA059032-02
Project IDNIH-11538491 on NIH RePORTER

Who could benefit from this research

Could help

PWID with co-occurring PTSD who are receiving or starting MOUD at community-based organizations and have access to telehealth services.

Less likely to help

Individuals without PTSD or those not enrolled in MOUD may not experience direct benefits.

What this research studies

This project brings PTSD care directly to community organizations that serve people who use opioids. It adapts Cognitive Processing Therapy for PWID with PTSD and delivers it through telehealth, with local staff providing in-person support to help patients stay on methadone or buprenorphine. By reducing PTSD symptoms, the program aims to improve emotional regulation and increase retention in life-saving MOUD care. The work is conducted in collaboration with three community-based sites to reach individuals who might not access traditional healthcare settings. If successful, this model could be scaled to similar community settings to support long-term recovery and reduce overdose risk.

Why it matters

Potential benefit: If successful, patients could experience better PTSD management and higher retention in MOUD, leading to fewer overdoses and better overall health.

How similar studies have gone: Previous adaptations of CPT have shown promise in PTSD treatment, but applying it onsite with MOUD in low-resource, community settings is a novel approach with early feasibility evidenced in prior work.

Where this research is happening

  • City College of New York
    New York, United States
    Active

Researchers

  • Principal investigator: Lopez-Castro, Teresa — City College of New York
  • Study coordinator: Lopez-Castro, Teresa

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.